X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse FDC LTD. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC LTD.   TEVA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TEVA PHARMA
Dec-13
FDC LTD./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1442,658-   
Low Rs792,309-   
Sales per share (Unadj.) Rs47.61,525.2-  
Earnings per share (Unadj.) Rs7.695.3-  
Cash flow per share (Unadj.) Rs9.0218.6-  
Dividends per share (Unadj.) Rs2.2583.41-  
Dividend yield (eoy) %2.03.4 60.2%  
Book value per share (Unadj.) Rs47.51,694.2-  
Shares outstanding (eoy) m177.83848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.6 143.7%   
Avg P/E ratio x14.626.1 56.1%  
P/CF ratio (eoy) x12.311.4 108.7%  
Price / Book Value ratio x2.31.5 159.7%  
Dividend payout %29.687.5 33.8%   
Avg Mkt Cap Rs m19,7842,105,694 0.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1,2210-   
Avg. sales/employee Rs ThNM28,777.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,797.7-  
INCOME DATA
Net Sales Rs m8,4591,293,392 0.7%  
Other income Rs m3940-   
Total revenues Rs m8,8521,293,392 0.7%   
Gross profit Rs m2,070354,196 0.6%  
Depreciation Rs m249104,546 0.2%   
Interest Rs m3125,404 0.1%   
Profit before tax Rs m2,184224,246 1.0%   
Minority Interest Rs m01,019 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-147,205 0.0%   
Tax Rs m606-2,738 -22.1%   
Profit after tax Rs m1,35380,797 1.7%  
Gross profit margin %24.527.4 89.4%  
Effective tax rate %27.7-1.2 -2,271.4%   
Net profit margin %16.06.2 256.1%  
BALANCE SHEET DATA
Current assets Rs m4,355873,552 0.5%   
Current liabilities Rs m1,792761,812 0.2%   
Net working cap to sales %30.38.6 350.8%  
Current ratio x2.41.1 212.0%  
Inventory Days Days4491 49.0%  
Debtors Days Days2596 25.7%  
Net fixed assets Rs m3,025422,450 0.7%   
Share capital Rs m1793,184 5.6%   
"Free" reserves Rs m8,2430-   
Net worth Rs m8,4531,436,714 0.6%   
Long term debt Rs m11661,340 0.0%   
Total assets Rs m10,5572,955,816 0.4%  
Interest coverage x71.49.8 726.7%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x0.80.4 183.1%   
Return on assets %13.13.6 364.9%  
Return on equity %16.05.6 284.6%  
Return on capital %23.54.9 476.7%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Net fx Rs m7910-   
CASH FLOW
From Operations Rs m1,485206,100 0.7%  
From Investments Rs m-620-73,029 0.8%  
From Financial Activity Rs m-753-247,231 0.3%  
Net Cashflow Rs m113-114,160 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 63.67 Rs / USD

Compare FDC LTD. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare FDC LTD. With: PFIZER  JUBILANT LIFE SCIENCES  ELDER PHARMA  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Sensex Trades on a Volatile Note; Power Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jan 19, 2018 02:43 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - SHASUN PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS